Naldemedine

Molecular mass: 570.646 g/mol  PubChem compound: 54732242

Therapeutic indications

Naldemedine is indicated for:

Opioid-induced constipation (OIC)

Population group: only adults (18 years old or older)

Naldemedine is indicated for the treatment of opioid-induced constipation (OIC) in adult patients who have previously been treated with a laxative.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Naldemedine is contraindicated in the following cases:

Gastrointestinal obstruction or perforation

at least one of
Gastrointestinal obstruction
Gastrointestinal perforation

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2021: RIZMOIC Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈